Skip to main content

Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.

Publication ,  Journal Article
Liu, T; Hsiung, J; Zhao, S; Kost, J; Sreedhar, D; Hanson, CV; Olson, K; Keare, D; Chang, ST; Bliden, KP; Gurbel, PA; Tantry, US; Roche, J ...
Published in: Nat Biomed Eng
December 2020

Accurate assays for the detection of antibodies to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) are essential for the control of the COVID-19 (coronavirus disease 2019) pandemic. Here, we report antibody and antibody-avidity assays, relying on near-infrared-fluorescence amplification by nanostructured plasmonic gold substrates, for the simultaneous detection of antibodies to the S1 subunit of the spike protein and to the receptor binding domain of SARS-CoV-2 in human serum and saliva, and for quantifying immunoglobulin avidities against coronavirus antigens from SARS-CoV-2, SARS-CoV-1 and the common-cold viruses OC43, HKU1, NL63 and 229E. The antibody assay detected immunoglobulin M in 87% (52 of 60) COVID-19-positive serum samples collected 6 or more days after symptom onset (and the immunoglobulins M and G in all 33 samples collected at least 15 days after symptom onset), and correctly classified 456 out of the 457 COVID-19-negative serum samples tested (424 of them collected before the pandemic, including 73 that were positive for other viruses). We used the antibody-avidity assay to study antibody-maturation patterns, anamnestic responses, and cross-immunity to the common-cold coronaviruses.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nat Biomed Eng

DOI

EISSN

2157-846X

Publication Date

December 2020

Volume

4

Issue

12

Start / End Page

1188 / 1196

Location

England

Related Subject Headings

  • Saliva
  • SARS-CoV-2
  • Pandemics
  • Immunoglobulin M
  • Immunoglobulin G
  • Humans
  • Female
  • COVID-19 Serological Testing
  • COVID-19
  • Antigens, Viral
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liu, T., Hsiung, J., Zhao, S., Kost, J., Sreedhar, D., Hanson, C. V., … Dai, H. (2020). Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng, 4(12), 1188–1196. https://doi.org/10.1038/s41551-020-00642-4
Liu, Tiancheng, Jessica Hsiung, Su Zhao, Jessica Kost, Deepika Sreedhar, Carl V. Hanson, Kjerstie Olson, et al. “Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.Nat Biomed Eng 4, no. 12 (December 2020): 1188–96. https://doi.org/10.1038/s41551-020-00642-4.
Liu T, Hsiung J, Zhao S, Kost J, Sreedhar D, Hanson CV, et al. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020 Dec;4(12):1188–96.
Liu, Tiancheng, et al. “Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.Nat Biomed Eng, vol. 4, no. 12, Dec. 2020, pp. 1188–96. Pubmed, doi:10.1038/s41551-020-00642-4.
Liu T, Hsiung J, Zhao S, Kost J, Sreedhar D, Hanson CV, Olson K, Keare D, Chang ST, Bliden KP, Gurbel PA, Tantry US, Roche J, Press C, Boggs J, Rodriguez-Soto JP, Montoya JG, Tang M, Dai H. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020 Dec;4(12):1188–1196.

Published In

Nat Biomed Eng

DOI

EISSN

2157-846X

Publication Date

December 2020

Volume

4

Issue

12

Start / End Page

1188 / 1196

Location

England

Related Subject Headings

  • Saliva
  • SARS-CoV-2
  • Pandemics
  • Immunoglobulin M
  • Immunoglobulin G
  • Humans
  • Female
  • COVID-19 Serological Testing
  • COVID-19
  • Antigens, Viral